open access
메뉴ISSN : 0376-4672
The aim of this study was to appraise the influence of conventional periodontal treatment on metabolic control in Korean type 2 diabetic patients. In addition,their periodontal change was compared with non-diabetic patients.Before and after treatment, it was performed to measure periodontal and metabolic indices in thirteen type 2 diabetic patients. Periodontal indices included plaque index, gingival index, bleeding on probing, probing pocket depth, gingival recession, and clinical attachment level. Metabolic indices included glycated hemoglobin(HbA1c), fasting plasma glucose, fasting plasma insulin, total cholesterol, triglyceride, and HDL-cholesterol. Plaque index, gingival index, bleeding on probing, probing pocket depth, and gingival recession showed significant improvements in the statistics. Diabetic patients showed no statistically significant differences in the changes of periodontal indices compared with non-diabetic patients. HbA1c values decreased in five of the thirteen subjects and fasting plasma glucose levels were reduced in four of the seven subjects after periodontal treatment. All five subjects whom HOMA values were calculated in showed the increases of insulin secretions. The results of this study ascertained the possibility of the better glycemic contol after conventional periodontal treatment in Korean type 2 diabetic patients and diabetes were well healed of their periodontal diseases after the treatment.
1. 강두희. 생리학, 제4판. 서울:신광출판사;1992:제15장 41-52.
2. 대한당뇨병학회. 당뇨병학, 제3판. 서울:고려의학;2005:1-271,310-332.
대한당뇨병학회. 당뇨병학, 제3판. 서울:고려의학;2005:1-271,310-332.
3. Manoucher-Pour M, Spagnuolo PJ, Rodman HM, et al. Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease. J Periodontol 1981;52:410-415.
4. McMullen JA, Van Dyke TE, Horoszewicz HU, Genco RJ. Neutrophil chemotaxsis in individuals with advanced periodontal disease and a genetic predisposition to diabetes mellitus. J Periodontol 1982;52:167-173.
5. Salvi GE, Collins JG, Yalda B, et al. Monocytic TNF-α secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol 1997;24:8-16.
6. Salvi GE, Yalda B, Collins JG, et al. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol 1997;68:127-135.
7. Engebretson SP, Hey-Hadavi J, Ehrhardt FJ, et al. Gingival crevicular fluid levels of interleukin-1β and glycemic control in patients with chronic periodon-titis and type 2 diabetes. J Peiodontol 2004;75:1203-1208.
8. Ficara AJ, Levin MP, GrowerMF, Kramer GD. A comparison of the glucose and protein content of gingival crevicular fluid from diabetics and nondiabetics. J Peiodontal Res 1975;10:171-175.
9. Sorsa T, Ingman T, Suomalainen K, et al. Cellular source and tetracycline inhibition of gingival crevicular fluid collagenase of patients with labile diabetes mellitus. J Clin Periodontol 1992;19:146-149.
10. Willershausen-Zonnchen B, Lemmen C, Hamm G. Influence of high glucose concentrations on glycosaminoglycan and collagen synthesis in cultured human gingival fibroblasts. J Clin Periodontol 1991;18:190-195.
11. Collin HL, Uusitupa M, Niskanen L, et al. Periodontal findings in elderly patients with non-insulin dependent diabetes mellitus. J Periodontol 1998;69:962-966.
12. Frantzis TG, Reeve CM, Brown AL. The ultrastructure of capillary basement membranes in the attached gingiva of diabetic and non-diabetic patients with periodontal disease. J Periodontol 1971;42:406-411.
13. Seppälä B, Sorsa T, Ainamo J. Morphometric analysis of cellular and vascular changes in gingival connective tissue in long-term insulin-dependent diabetes. J Periodontol 1997;68:1237-1245.
14. Schmidt AM, Weidman E, Lalla E, et al. Advanced glycated end products(AGEs) induce oxidant stress in the gingiva:A potential mechanism underlying accelerated periodontal disease associated with diabetes. J Periodontal Res 1996;31:508-515.
15. Unlu F, Gurdal Guneri P, Hekimgil M, et al. Expression of vascular endothelial growth factor in human periodontal tissues:Comparison of healthy and diabetic patients. J Peiodontol 2003;74:181-187.
16. Katz J, Bhattacharyya I, Farkhondeh-Kish F, et al. Expression of the receptor of advanced glycation end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease:A study utilizing immunohisto- chemistry and RT-PCR. J Clin Periodontol 2005;32:40-44.
17. Brian LM & Thomas WO. Diabetes mellitus and periodontal diseases. J Periodontol 2006;77:1289-1303.
18. Taylor GW. Bidirectional interrelationships between diabetes and periodontal disease:an epidemiologic perspective. Ann periodontol 2001;6:99-112.
19. Hamdy Nassar, Alpdogan Kantarci, Thomas E. Van Dyke. Diabetic periodontitis:a model for activated innate immunity and impaired resolution of inflammation. Periodontology 2000 2007;43:233-244.
20. Taylor GW, Burt BA, Becker MP, et al. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol 1996;67:1085-1093.
21. Thorstensson H, Kuylensteirna J, Hugoson A. Medical status and complications in insulin-dependent diabetics. J Clin Periodontol 1996;23:194-202.
22. Saremi A, Nelson RG, Tulloch-Reid M, et al. Periodontal disease and mortality in type 2 diabetes. Diabetes Care 2005;28:27-32.
23. Williams RC Jr, Mahan CJ. Periodontal disease and diabetes in young adults. JAMA 1960;67:1094-1102.
24. Miller LS, Manwell MA, Newbold D, et al. The relationship between reduction in periodontal inflammation and diabetes control:A report of 9 cases. J Periodontol 1992;63:843-848.
25. Seppala B, Seppala M, Ainamo J. A longitudinal study on insulin-dependent diabetes mellitus and periodontal disease. J Clin Periodontol 1993;20:161-165.
26. Seppala B, Ainamo J. A site-by-site follow-up study on the effect of controlled versus poorly controlled insulin-dependent diabetes mellitus. J Clin Periodontol 1994;21:161-165.
27. Grossi SG, Skrepcinski FB, Decaro T, et al.Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol 1997;68:713-719.
28. Stewart JE, Wager KA, Friedlander AH & Zadeh HH. The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus. J Clin Periodontol 2001;28:306-310.
29. Iwamoto Y, Nishmura F, Nakagawa M, et al. The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol 2001;72:774-778.
30. Kiran M, Arpak N, Unsal E, et al. The effect of improved periodontal health on metabolic control in type 2 diabetes mellitus. J Clin Periodontol 2005;32:266-272.
31. Christgau M, Palitzsch KD, Schmalz G, et al. Healing response to non-surgical periodontal therapy in patients with diabetes mellitus: Clinical, microbiological, and immunological results. J Clin Peiodontol 1998;25:112-124.
32. Tervonen T, Knuuttila M, Pohjamo L, et al. Immetiate response to non-surgical periodontal treatment in subjects with diabetes millitus. J Clin Periodontol 1991;18:65-68.
33. Ricardo FA, Ana N, Antonio B. Clinical and metabolic changes after conven-tional treatment of type 2 diabetic patients with chronic periodontitis. J Periodontol 2006;77:591-598.
34. Westfelt E, Rylander H, Blohme G, et al. The effect of periodontal therapy in diabetics. Results after 5 years. J Clin Periodontol 1996;23:92-100.
35. Tervonen T, Karjalainen K. Periodontal disease related to diabetic status:A pilot study of the response to periodontal therapy in type 1 diabetes. J Clin Periodontol 1997;24:505-510.
36. Albert van de Wiel. Diabetes mellitus and alcohol. Diabetes Metab Res Rev 2004;20:263-267
37. Nilsson PM, Gudbjörnsdottir S, Eliasson B, et al. Smoking is associated with increased HbA1c values and microalbuminuria in patients with diabetes-data from the National Diabetes Register in Sweden. Diabetes Metab 2004;30:261-268.
38. Western Pacific Regional Office of the World Health Organization, The international Obesity Task Force:The Asia-Pacific perspective:redefining obesity and its treatment. Sydney:Health Communications Australia; 2000.
39. 정혜원, 김대중, 김하동 등. 새로운 비만기준에 따른 대사증후군의 유병률. 당뇨병 2002;26:431-442.
40. 이재현, 최상묵, 이만섭, 한수부, 김종관 등. 기초 및 임상치주과학, 초판. 서울:대림출판사;1987:189-223.
41. Matthews DR, Hosker JP, Rudenski AS. Homeostasis model assessment. Diabetologia 1985;28:412-419.
42. 장현하, 김진우, 류미숙 등. 한국인 제2형 당뇨병환자에서의 Homeostasis Model Assessment. 당뇨병 2002;26:296-305.
43. 김지연, 지재환, 김현진 등. 연령증가와 비만에 따른 인슐린 분비능과 감수성의 변화 . 당뇨병 2005;29:39-47.
44. 송경은, 김대중, 박지원 등.한국인 제2형 당뇨병환자의 인슐린분비능과 인슐린저항성에 따른 임상적 특성. 당뇨병 2007;31:123-129.
45. 이재현, 최상묵, 이만섭, 한수부, 김종관 등. 기초 및 임상치주과학, 초판. 서울:대림출판사;1987:231-245.
46. 유해영. 제2형 당뇨 환자의 식습관, 운동습관, 스트레스, 당화혈색소와의 관련성에 관한 연구. 2001. 이화여자대학교 대학원 석사학위논문.
47. Frenzel MP, McCaul KD, Glasgow RE & Schafer LC. The relationship stress and coping to regimen adherence and glycemic control of diabetes. J Social and Clinical Psychology 1988;6:77-87.
48. Peyrot MF & Mcmurry JF. Stress buffering and glycemic control-The role of coping styles. Diabetes Care 1992;15:842-846.
49. 심완섭, 김수경, 김혜진 등. 한국인 제2형 당뇨병 환자에서 Homeostasis Model Assessment 법을 이용한 인슐린저항성 및 인슐린분비장애의 상대적 중요성에 대한 평가. 당뇨병 2005;29:215-223.
50. 윤용석, 박석원, 송영득 등. Homeostasis Model Assessment법을 이용한 인슐린 저항성 평가의 한계.당뇨병 2000;24:541-551.
51. 강두희. 생리학, 제4판. 서울:신광출판사;1992:제13장1-15.
52. Chin-Lin Tseng, Michael Brimacombe, Minge Xie, et al. Seasonal patterns in monthly hemoglobin A1c values. Am J Epidemiol 2005;161:565-574.
53. Wen Wei Liang. Seasonal changes in preprandial glucose, A1c, and blood pressure in diabetic patients. Diabetes Care 2007;30:2501-2502.
54. 대한당뇨병학회. 당뇨병학, 제3판. 서울:고려의학;2005:441-452.
55. 허갑범, 이현철, 정윤석 등. 인슐린비의존형 당뇨병 환자에서 인슐린 분비능력이 당질 및 지질 대사에 미치는 영향. 대한내과학회지 1994;47:295-304.
56. Gadi R, Samaha FF. Dyslipidemia in type 2 diabetes mellitus. Curr Diab Rep 2007;7:228-234.
57. Biesbroeck RC, Albers JJ, Wahl PW, et al. Abnormal composition of high density lipoproteins in noninsulin-dependent diabetics. Diabetes 1982;31:126-131.
58. 민헌기. 한국인 당뇨병의 임상적 특성. 당뇨병 1992;16:163-174.
59. 허갑범. 한국인 당뇨병의 특성과 치료. 당뇨병 1997;21:S7-14.
60. 윤건호. 한국 제2형 당뇨병환자의 병인. 당뇨병 2007;31:397-403.